Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Dalamaga

Showing results (51-60 of 261) with videos related to

Pageof 27
Sort By:
Current Obesity Reports|October 16, 2023
Correction to: Update on the Obesity Epidemic: After the Sudden Rise, Is the Upward Trajectory Beginning to Flatten?Chrysi Koliaki, Maria Dalamaga, Stavros Liatis
Metabolism Open|February 16, 2022
Gut mycobiome as a promising preventive and therapeutic target for metabolic disordersMaria Dalamaga, Liaoyuan Zheng, Junli Liu
Metabolism Open|March 21, 2022
Could gut mycobiome play a role in NAFLD pathogenesis? Insights and therapeutic perspectivesDimitrios Fotis, Junli Liu, Maria Dalamaga
Metabolism Open|April 20, 2026
COVID-19 and metabolic health: Lessons from a global pandemicMaria Dalamaga, Irene Karampela, Junli Liu
Metabolism: Clinical and Experimental|June 5, 2020
Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19Maria Dalamaga, Irene Karampela, Christos S Mantzoros
Cancers|March 29, 2023
Perspectives and Challenges of COVID-19 with Obesity-Related CancersMaria Dalamaga, Narjes Nasiri-Ansari, Nikolaos Spyrou
Metabolism Open|August 20, 2020
Diverting epithelial-to-mesenchymal transition to transform cancer cells to adipocytes: A promising strategy to stop metastasisMaria Dalamaga, Gerasimos S Christodoulatos, Junli Liu
Metabolism Open|April 29, 2021
Prediabetes screening: Questionable benefits in the golden yearsDimitrios Tsilingiris, Natalia G Vallianou, Maria Dalamaga
Metabolism: Clinical and Experimental|May 19, 2020
Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?Maria Dalamaga, Irene Karampela, Christos S Mantzoros
Metabolism Open|February 14, 2023
Could exercise hormone irisin be a therapeutic agent against Parkinson's and other neurodegenerative diseases?Konstantinos I Avgerinos, Junli Liu, Maria Dalamaga
Pageof 27

Showing results (51-60 of 261) with videos related to

Sort By:
Pageof 27
Current Obesity Reports|October 16, 2023
Correction to: Update on the Obesity Epidemic: After the Sudden Rise, Is the Upward Trajectory Beginning to Flatten?Chrysi Koliaki, Maria Dalamaga, Stavros Liatis
Metabolism Open|February 16, 2022
Gut mycobiome as a promising preventive and therapeutic target for metabolic disordersMaria Dalamaga, Liaoyuan Zheng, Junli Liu
Metabolism Open|March 21, 2022
Could gut mycobiome play a role in NAFLD pathogenesis? Insights and therapeutic perspectivesDimitrios Fotis, Junli Liu, Maria Dalamaga
Metabolism Open|April 20, 2026
COVID-19 and metabolic health: Lessons from a global pandemicMaria Dalamaga, Irene Karampela, Junli Liu
Metabolism: Clinical and Experimental|June 5, 2020
Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19Maria Dalamaga, Irene Karampela, Christos S Mantzoros
Cancers|March 29, 2023
Perspectives and Challenges of COVID-19 with Obesity-Related CancersMaria Dalamaga, Narjes Nasiri-Ansari, Nikolaos Spyrou
Metabolism Open|August 20, 2020
Diverting epithelial-to-mesenchymal transition to transform cancer cells to adipocytes: A promising strategy to stop metastasisMaria Dalamaga, Gerasimos S Christodoulatos, Junli Liu
Metabolism Open|April 29, 2021
Prediabetes screening: Questionable benefits in the golden yearsDimitrios Tsilingiris, Natalia G Vallianou, Maria Dalamaga
Metabolism: Clinical and Experimental|May 19, 2020
Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?Maria Dalamaga, Irene Karampela, Christos S Mantzoros
Metabolism Open|February 14, 2023
Could exercise hormone irisin be a therapeutic agent against Parkinson's and other neurodegenerative diseases?Konstantinos I Avgerinos, Junli Liu, Maria Dalamaga
Pageof 27